Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole

被引:15
|
作者
Rath, PM [1 ]
机构
[1] Univ Essen Gesamthsch, Inst Med Mikrobiol, D-45122 Essen, Germany
关键词
D O I
10.1093/jac/41.5.567
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibility testing of 27 Aspergillus reference stains belonging to five species was performed using the microdilution broth method with yeast nitrogen broth and RPMI-1640. Similar results were found using the two media. The strains of Aspergillus fumigatus (n = 8) and Aspergillus niger (n = 4) had MICs of amphotericin B in the range 0.125-0.5 mg/L. In contrast, nine out of 13 strains of Aspergillus flavus and Aspergillus nidulans had MICs in the range 2-16 mg/L. All strains had MICs of itraconazole in the range 0.03-0.5 mg/L. It is concluded that both media can be used for testing. Susceptibility testing to amphotericin B is recommended in clinical settings.
引用
收藏
页码:567 / 570
页数:4
相关论文
共 50 条
  • [1] Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
    Ramondenc, I
    Pinel, C
    Ambroise-Thomas, P
    Grillot, R
    [J]. MEDICAL MYCOLOGY, 1998, 36 (02) : 69 - 73
  • [2] In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole
    Dannaoui, E
    Persat, F
    Monier, MF
    Borel, E
    Piens, MA
    Picot, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) : 553 - 555
  • [3] In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole
    Chryssanthou, E
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (05) : 509 - 512
  • [4] Evaluation of different in vitro procedures for testing amphotericin B and itraconazole susceptibility of Aspergillus fumigatus -: Antifungal susceptibility testing of Aspergillus fumigatus
    Tortorano, AM
    Dannaoui, E
    Cogliati, M
    Piens, MA
    Rigoni, AL
    Grillot, R
    Viviani, MA
    [J]. JOURNAL DE MYCOLOGIE MEDICALE, 2000, 10 (03): : 123 - 127
  • [5] Hypha growth inhibition study for susceptibility testing of Aspergillus terreus to amphotericin B, voriconazole and itraconazole
    Teixeira-Loyola, A. B. A.
    Moretti, M. L.
    Trabasso, P.
    Kamei, K.
    Mikami, Y.
    Taguchi, H.
    Schreiber, A. Z.
    [J]. MYCOSES, 2012, 55 : 113 - 113
  • [6] Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species
    Arikan, S
    Lozano-Chiu, M
    Paetznick, V
    Nangia, S
    Rex, JH
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) : 3946 - 3951
  • [8] EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
    Arendrup, M. C.
    Cuenca-Estrella, M.
    Lass-Floel, C.
    Hope, W. W.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (07) : E248 - E250
  • [9] In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B
    Abraham, OC
    Manavathu, EK
    Cutright, JL
    Chandrasekar, PH
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (01) : 7 - 11
  • [10] In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin
    Shi Jun-yan
    Xu Ying-chun
    Shi Yi
    Lue Huo-xiang
    Liu Yong
    Zhao Wang-sheng
    Chen Dong-mei
    Xi Li-yan
    Zhou Xin
    Wang He
    Guo Li-na
    [J]. CHINESE MEDICAL JOURNAL, 2010, 123 (19) : 2706 - 2709